Literature DB >> 25609516

Well-managed warfarin is superior to NOACs.

Murray Trusler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25609516      PMCID： PMC4301757     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  10 in total

Review 1.  Approach to the new oral anticoagulants in family practice: part 1: comparing the options.

Authors:  James Douketis; Alan David Bell; John Eikelboom; Aaron Liew
Journal:  Can Fam Physician       Date:  2014-11       Impact factor: 3.275

2.  Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.

Authors:  James Douketis; Alan David Bell; John Eikelboom; Aaron Liew
Journal:  Can Fam Physician       Date:  2014-11       Impact factor: 3.275

3.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Authors:  Manesh R Patel; Kenneth W Mahaffey; Jyotsna Garg; Guohua Pan; Daniel E Singer; Werner Hacke; Günter Breithardt; Jonathan L Halperin; Graeme J Hankey; Jonathan P Piccini; Richard C Becker; Christopher C Nessel; John F Paolini; Scott D Berkowitz; Keith A A Fox; Robert M Califf
Journal:  N Engl J Med       Date:  2011-08-10       Impact factor: 91.245

4.  Guidelines on oral anticoagulation: third edition.

Authors: 
Journal:  Br J Haematol       Date:  1998-05       Impact factor: 6.998

5.  Anticoagulation management by community pharmacists in New Zealand: an evaluation of a collaborative model in primary care.

Authors:  Jeff Harrison; John P Shaw; Jenny E Harrison
Journal:  Int J Pharm Pract       Date:  2014-09-23

6.  Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.

Authors:  Mattias Wieloch; Anders Själander; Viveka Frykman; Mårten Rosenqvist; Niclas Eriksson; Peter J Svensson
Journal:  Eur Heart J       Date:  2011-05-26       Impact factor: 29.983

7.  EMPoWarMENT: Edmonton pediatric warfarin self-management pilot study in children with primarily cardiac disease.

Authors:  M E Bauman; K Black; M L Bauman; A A K Bruce; S Kuhle; L Bajzar; M P Massicotte
Journal:  Thromb Res       Date:  2010-06-26       Impact factor: 3.944

8.  Apixaban versus warfarin in patients with atrial fibrillation.

Authors:  Christopher B Granger; John H Alexander; John J V McMurray; Renato D Lopes; Elaine M Hylek; Michael Hanna; Hussein R Al-Khalidi; Jack Ansell; Dan Atar; Alvaro Avezum; M Cecilia Bahit; Rafael Diaz; J Donald Easton; Justin A Ezekowitz; Greg Flaker; David Garcia; Margarida Geraldes; Bernard J Gersh; Sergey Golitsyn; Shinya Goto; Antonio G Hermosillo; Stefan H Hohnloser; John Horowitz; Puneet Mohan; Petr Jansky; Basil S Lewis; Jose Luis Lopez-Sendon; Prem Pais; Alexander Parkhomenko; Freek W A Verheugt; Jun Zhu; Lars Wallentin
Journal:  N Engl J Med       Date:  2011-08-27       Impact factor: 91.245

9.  Dabigatran versus warfarin in patients with atrial fibrillation.

Authors:  Stuart J Connolly; Michael D Ezekowitz; Salim Yusuf; John Eikelboom; Jonas Oldgren; Amit Parekh; Janice Pogue; Paul A Reilly; Ellison Themeles; Jeanne Varrone; Susan Wang; Marco Alings; Denis Xavier; Jun Zhu; Rafael Diaz; Basil S Lewis; Harald Darius; Hans-Christoph Diener; Campbell D Joyner; Lars Wallentin
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

10.  A method to determine the optimal intensity of oral anticoagulant therapy.

Authors:  F R Rosendaal; S C Cannegieter; F J van der Meer; E Briët
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249
  10 in total
  3 in total

1.  Personalized Anticoagulation: Optimizing Warfarin Management Using Genetics and Simulated Clinical Trials.

Authors:  Kourosh Ravvaz; John A Weissert; Christian T Ruff; Chih-Lin Chi; Peter J Tonellato
Journal:  Circ Cardiovasc Genet       Date:  2017-12

Review 2.  Interventions and Strategies to Improve Oral Anticoagulant Use in Patients with Atrial Fibrillation: A Systematic Review of Systematic Reviews.

Authors:  Siok Shen Ng; Nai Ming Lai; Surakit Nathisuwan; Nathorn Chaiyakunapruk
Journal:  Clin Drug Investig       Date:  2018-07       Impact factor: 2.859

3.  Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants.

Authors:  Lulu Gao; Mina Tadrous; Sandra Knowles; Muhammad Mamdani; J Michael Paterson; David Juurlink; Tara Gomes
Journal:  Healthc Policy       Date:  2017-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.